Xenon Pharmaceuticals Inc. (XENE)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
39
$2.69B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| FMR LLC | Aug 13, 2026 | $582.35M |
| BlackRock, Inc. | Aug 7, 2026 | $454.06M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Aug 14, 2026 | $196.06M |
| JPMORGAN CHASE & CO | Aug 12, 2026 | $157.38M |
| Capital International Investors | Aug 12, 2026 | $142.55M |
XENE's filings are public. The insight is one click away.
Scrutar's AI reads every XENE filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze XENE filingsNo credit cardAI reports included on the free plan
Never miss a XENE filing.
Get an email when XENE files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.